Madison Scottsdale’s Pfizer PFE Stock Holding History

Madison Scottsdale’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$92K	Hold	3,162	–	–	0.08%	14
2013 Q3	$86K	Hold	3,162	–	–	0.08%	44
2013 Q2	$84K	Buy	+3,162	New	+$87.4K	0.08%	62

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Madison Scottsdale's PFE Position: Q4 2013 in Review

Madison Scottsdale held its Pfizer (PFE) position steady in Q4 2013 at 3,162 shares worth $92K. The position accounts for 0.08% of the portfolio, ranked #14.

Madison Scottsdale first reported a position in PFE in Q2 2013 and has held it in 3 quarters since. 1,737 funds tracked by Wall St. Rank hold PFE as of Q4 2013.

Madison Scottsdale held 3,162 shares of Pfizer worth $92K as of Q4 2013.
Madison Scottsdale left its Pfizer share count unchanged in Q4 2013.
Pfizer made up 0.08% of Madison Scottsdale's portfolio in Q4 2013, its #14 holding.
Madison Scottsdale first reported a position in Pfizer in Q2 2013 and has held it in 3 quarters since.
1,737 funds tracked by Wall St. Rank held Pfizer as of Q4 2013.

Based on Madison Scottsdale's 13F filing for Q4 2013, filed 12 Feb 2014.